Total Hemoglobin Concentration
Total Hemoglobin Concentration - Related Videos
06:37
Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source
0 Views •
Cited by 31 •
2013
Here we describe a growth assay for Staphylococcus aureus using hemoglobin as the sole source of available nutrient iron. This assay establishes the role of bacterial factors involved in hemoglobin-derived iron acquisition.
01:24
Hemoglobin
0 Views •
2024
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well. When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
05:18
A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering
0 Views •
Cited by 1 •
2016
A photo-thermal angular light scattering (PT-AS) sensor enables the rapid and chemical-free hemoglobin assay of nanoliter-scale blood samples. Here, details of the PT-AS setup and a measurement protocol for the hemoglobin concentration in blood are provided. Representative results for anemic blood samples are also presented.
04:51
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
0 Views •
2025
This video demonstrates a method to generate a rat model of neonatal intraventricular hemorrhage. In this procedure, an anesthetized rat pup is injected with hemoglobin into the lateral ventricle of the brain. The hemoglobin causes oxidative stress and releases heme, simulating intraventricular hemorrhage. The resulting damage to brain tissues, driven by reactive oxygen species and inflammatory cytokines, leads to ventricular enlargement, a common consequence of intraventricular hemorrhage.
09:49
Solutions and Concentrations
0 Views •
2023
Source: Laboratory of Dr. Michael Evans — Georgia Institute of Technology A solution is a homogeneous mixture containing some components in small amounts, called solutes, and one component in a large amount, called the solvent. Solid-liquid solutions contain one or more solid solutes dissolved in a liquid solvent. Solutions are ubiquitous in chemistry: they are used to store and handle small amounts of material, carry out chemical reactions, and develop materials with controllable properties.
FAQs
Red-cell lysis releases the hemoglobin contained within erythrocytes into the measured sample. That step makes the total hemoglobin available for optical analysis rather than leaving it enclosed in intact cells. The resulting sample can then be evaluated by spectrophotometry, allowing the measured signal to represent hemoglobin across the blood volume being analyzed.
A stabilized hemoglobin derivative provides an alternative optical measurement form after red-cell lysis. The assay therefore does not depend exclusively on measuring hemoglobin in its initially released state. Spectrophotometric absorbance of either the released hemoglobin or the stabilized derivative is used to determine the amount present in the sampled blood volume.
A higher or lower amount per blood volume changes the oxygen-transport capacity represented by that sample. For bioengineered systems, the measurement provides a quantitative basis for examining whether altered red-cell composition, blood substitutes, or oxygen-carrying biomaterials could support oxygen delivery. It can therefore connect composition measurements with overall physiological performance.
A typical workflow begins with a blood sample, followed by red-cell lysis. The released hemoglobin, or a stabilized hemoglobin derivative, is then assessed through spectrophotometry by measuring absorbance. The result is interpreted as an amount of hemoglobin relative to the analyzed blood volume, which allows comparisons among samples or engineered conditions.
Total Hemoglobin Concentration supports evaluation of blood substitutes, oxygen-carrying biomaterials, microfluidic systems, and tissue-engineered constructs. In each setting, the measurement helps characterize the hemoglobin available within the system or sample. That information can be used alongside engineered changes to consider potential effects on oxygen delivery and overall physiological performance.
By quantifying hemoglobin in a defined blood volume, the assay gives a common measurement for comparing conditions associated with anemia, blood loss, or altered red-cell composition. In bioengineering studies, those comparisons can indicate whether an intervention changes the oxygen-delivery potential or broader physiological performance of the blood or tissue-engineered construct.